Biodesix, Inc. Common Stock
€19.04
EUR
Last updated on --.
24h volume86.24K
24h highest20.3102 EUR
24h lowest18.6944 EUR
24h Price movement+3.40%
BDSX recent prices
24 Hours
+3.40%+€0.62546
30 days
+5.10%+€0.9686
60 days
+48.54%+€6.519
90 days
+53.10%+€6.919
Key data
Previous close18.4164 EUR
Market cap191.93M EUR
Volume86.24K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-2.6843 EUR
Net income (FY)-27.76M EUR
Revenue (FY)83.48M EUR
Last report dateMay 4, 2026
About Biodesix, Inc. Common Stock
HeadquartersLOUISVILLE
Employees (FY)334.00
Revenue per employee (FY)249.94K EUR
Net income per employee (FY)-83.12K EUR
Listed onNasdaq
BDSX conversion tables
 |  |
|---|---|
| 0.5 BDSX | 9.520 EUR |
| 1 BDSX | 19.04 EUR |
| 5 BDSX | 95.2 EUR |
| 10 BDSX | 190.41 EUR |
| |
|---|---|
| 0.5 EUR | 0.026258 BDSX |
| 1 EUR | 0.052516 BDSX |
| 5 EUR | 0.26258 BDSX |
| 10 EUR | 0.52516 BDSX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
BDSX is trading at €19.04, +3.40% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BDSX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BDSX is currently trading at €19.04, +3.40% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BDSX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the SERVICES-MEDICAL LABORATORIES sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BDSX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BDSX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BDSX's historical range and other companies in the SERVICES-MEDICAL LABORATORIES sector.
Biodesix, Inc. Common Stock's market cap is currently 191.93M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume86.24K
24h highest20.3102 EUR
24h lowest18.6944 EUR
24h Price movement+3.40%
Start trade with BDSX Perpetual
Sign up to trade